Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
Do you simply remember that SpO2 is safe if it is 95% or higher, and dangerous if it drops below 90%? In reality, applying this understanding to certain patients, such as those with COPD, can lead to ...
A prespecified analysis of the MAPLE-HCM trial showed that aficamten monotherapy provided greater improvements in a wide range of exercise performance measures compared with metoprolol in patients ...
Definitions of hypoxaemia, hypoxia, type 1 respiratory failure and hyperoxaemia Definition of hypercapnia and type 2 respiratory failure Definition of acidosis (respiratory acidosis and metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results